Newsroom
- Press Release
26 April 25
CuraTeQ Biologics receives CHMP positive opinion for Dazublys – Trastuzumab biosimilar
Read more - Press Release
10 April 25
CuraTeQ Biologics successfully completes Phase I study for Denosumab biosimilar
Read more - Press Release
31 January 25
CuraTeQ Biologics receives CHMP positive opinion for Pegfilgrastim biosimilar
Read more